FGF9 and urinary bladder carcinoma: In addition, based on TCGA data, higher expression of FGF9 was also associated with worse overall survival in bladder carcinoma patients (Hazard ratio = 3.168 (95% CI = 1.750-5.735), logrank P = 2.355e -05, Figure 3B).